Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Risk of Cancer in Relatives of Patients with Myelodysplastic Neoplasia and Acute Leukemias

Nikolaj Juul Nitschke, Klaus Rostgaard, Henrik Hjalgrim, Mette Klarskov Andersen, Kirsten Grønbæk

Blood (2023) 142 (Supplement 1): 7442.

https://doi.org/10.1182/blood-2023-173784

Published: 2023

Journal Articles

Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10 % Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL

Sarka Pavlova, Jitka Malcikova, Lenka Radova, Silvia Bonfiglio, Jack B. Cowland, Christian Brieghel, Mette Klarskov Andersen, Maria Karypidou, Bella V Biderman, Michael Doubek, Gregory Lazarian, Inmaculada Rapado, Matthijs Vynck, Naomi Porret, Martin Andres, Dina Rosenberg, Dvora Sahar, Carolina Martinez-Laperche, Ismael Buño Borde, Andrew Hindley, Julio Bravo Sánchez, José García-Marco, Alicia Serrano, Blanca Ferrer Lores, Concepción Fernández-Rodriguez, Beatriz Bellosillo, Stephan Stilgenbauer, Eugen Tausch, Hero Nikdin, Fiona Quinn, Emer Atkinson, Lisette Van De Corput, Cafer Yildiz, Cristina Bilbao, Yanira Florido, Christian Thiede, Caroline Schuster, Anastazja Stoj, Sylwia Czekalska, Anastasia Chatzidimitriou, Stamatia Laidou, Audrey Bidet, Charles Dussiau, Friedel Nollet, Giovanna Piras, Tereza Borosova, Terezia Kurucova, Maria Monne, Svetlana Smirnova, Evgeny Nikitin, Ivan Sloma, Marie-Helene Delfau, Laetitia Largeaud, Loic Ysebaert, Peter J. M. Valk, Amy Christian, Renata Walewska, Marta Sebastião, Maria Gomes da Silva, Piero Galieni, Mario Angelini, Davide Rossi, Valeria Spina, Sónia Matos, Vânia Martins, David Donaldson, Tomasz Stoklosa, Monika Pepek, Panagiotis Baliakas, Rafa Andreu, Irene Luna, Tiina Kahre, Ülle Murumets, Sophie Laird, Daniel Ward, Miguel Alcoceba, Ana Balanzategui, Lydia Scarfo, Francesca Gandini, Ettore Zapparoli, Adoracion Blanco, Pau Abrisqueta Costa, Ana E. Rodriguez, Maria Rocio Benito Sanchez, Frédéric Davi, Clothilde Bravetti, Paula Gameiro, Joaquin Martinez-Lopez, Barbara Tazon, Fanny Baran-Marszak, Zadie Davies, Mark Caterwood, Andrey B Sudarikov, Richard Rosenquist, Carsten Utoft Niemann, Kostas Stamatopoulos, Paolo Ghia, Sarka Pospisilova

Blood (2023) 142 (Supplement 1): 200.

https://doi.org/10.1182/blood-2023-173235

Published: 2023

Journal Articles

Overall Survival in Patients with Ccus Depends on Presence of Anemia

Dicte Træden, Morten Tulstrup, Morten Munk Johansen, Andreas Due Ørskov, Claus Marcher, Klas Raaschou-Jensen, Anne Stidsholt Roug, Marianne Tang Severinsen, Bo Porse, Kim Theilgaard-Mönch, Jakob Jespersen, Jack B. Cowland, Lene Sjö, Mette Klarskov Andersen, Kirsten Grønbæk, Jakob Werner Hansen

Blood (2023) 142 (Supplement 1): 1864.

https://doi.org/10.1182/blood-2023-177879

Published: 2023

Journal Articles

Germline Variant in ZCCHC8 Is Associated with Pulmonary Fibrosis, Bone Marrow Failure, Liver Inflammation, Early Grey Hair and Short Telomer Length

Nikolaj Juul Nitschke, Anne Marie Jelsig, Mette Klarskov Andersen, Kirsten Grønbæk

Blood (2023) 142 (Supplement 1): 5668.

https://doi.org/10.1182/blood-2023-174452

Published: 2023

Journal Articles

Acquired Loss of a Sex Chromosome Is a Positive Prognostic Factor for Patients with Multiple Myeloma Undergoing ASCT

Simon Husby, Morten Tulstrup, Mads Harsløf, Christian Nielsen, Marianne Antonius Jakobsen, Eva Kannik Hastrup, Lene Hyldahl Ebbesen, Mette Klarskov Andersen, Maroulio Pertesi, Björn Nilsson, Carsten Utoft Niemann, Agoston Gyula Szabo, Niels Frost Andersen, Niels Abildgaard, Kirsten Grønbæk, Annette Juul Vangsted

Blood (2022) 140 (Supplement 1): 4832–4833.

https://doi.org/10.1182/blood-2022-169982

Published: 2022

Journal Articles

The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy

Agoston Gyula Szabo, Jonathan Thorsen, Katrine Fladeland Iversen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Emil Hermansen, Lise Mette Rahbek Gjerdrum, Søren Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Noergaard Strandholdt, Mette Klarskov Andersen, Annette J. Vangsted

Blood (2021) 138 (Supplement 1): 3779.

https://doi.org/10.1182/blood-2021-152070

Published: 2021

Journal Articles

Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial

Staffan Holmberg-Thydén, MD, Inge Høgh Dufva, MDPhD, Anne Ortved Gang, MDPhD, Marie Fredslund Breinholt, MD, Lone Schejbel, PhD, Mette Klarskov Andersen, MD DMSc, Mohammad Kadivar, PhD, Inge Marie Svane, Prof,MDPhD, Kirsten Grønbæk, Prof,MDDMSc, Sine Reker Hadrup, Prof, Daniel El Fassi, MDPhD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-142806

Published: 2020

Journal Articles

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Jakob Werner Hansen, MD, Morten Munk Johansen, MD, Maj Karoline Westman, MSc, Leonie Saft, MD PhD, Lene Dissing Sjö, MD PhD, Claus Werenberg Marcher, MD PhD, Mette Skov Holm, MD PhD, Marios Dimitriou, PhD, Mohsen Karimi, PhD, Klas Raaschou-Jensen, MD, Andreas Birkedal Glenthøj, MD PhD, Marianne Tang Severinsen, MD PhD, Eva Hellström-Lindberg, MD PhD, Mette Klarskov Andersen, MD DMSc, Kirsten Grønbæk, Professor, MD DMSc

Blood (2018) 132 (Supplement 1): 794.

https://doi.org/10.1182/blood-2018-99-110767

Published: 2018

Journal Articles

Intra-Tumoral Blast Heterogeneity and Implications for Minimal Residual Disease Detection in T-Cell Acute Lymphoblastic Leukemia

Nina Friesgaard Öbro, Lars Peter Ryder, Hans Ole Madsen, Mette Klarskov Andersen, Birgitte Klug Albertsen, Peder Skov Wehner, Steen Rosthoej, Nina Toft, Thomas Leth Frandsen, Kjeld Schmiegelow, Hanne Vibeke Marquart

Blood (2014) 124 (21): 1076.

https://doi.org/10.1182/blood.V124.21.1076.1076

Published: 2014

Journal Articles

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML

Marianne Bach Treppendahl, Xiangning Qiu, Alexandra Søgaard, Xiaojing Yang, Cecilie Nandrup-Bus, Christoffer Hother, Mette Klarskov Andersen, Lars Kjeldsen, Lars Möllgaard, Eva Hellström-Lindberg, Johan Jendholm, Bo T. Porse, Peter A. Jones, Gangning Liang, Kirsten Grønbæk

Blood (2012) 119 (1): 206–216.

https://doi.org/10.1182/blood-2011-06-362541

Published: 2012

Includes: Supplemental data

Journal Articles

MicroRNA-130a–mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors

Mattias Häger, Corinna Cavan Pedersen, Maria Torp Larsen, Mette Klarskov Andersen, Christoffer Hother, Kirsten Grønbæk, Hanne Jarmer, Niels Borregaard, Jack Bernard Cowland

Blood (2011) 118 (25): 6649–6659.

https://doi.org/10.1182/blood-2011-03-339978

Published: 2011

Includes: Supplemental data

Journal Articles

Mir-130a-Mediated Downregulation of SMAD4 Contributes to Reduced Sensitivity to TGFβ Stimulation in Promyelocytic Cells,

Mattias Hager, Corinna Cavan Pedersen, Maria Torp Larsen, Mette Klarskov Andersen, MD, Christoffer Hother, MD, Kirsten Grønbæk, MD, DMSc, Hanne Jarmer, Niels Borregaard, Jack B Cowland

Blood (2011) 118 (21): 3383.

https://doi.org/10.1182/blood.V118.21.3383.3383

Published: 2011

Journal Articles

Allelic Methylation Levels of the Non-Coding RNA Gene VTRNA2-1 Located on Chromosome 5q31.1 Predict Outcome in AML,

Marianne B. Treppendahl, MD, Xiangning Qiu, MD, Alexandra Søgaard, MSc, Cecilie Nandrup-Bus, MSc, Christoffer Hother, MD, Mette Klarskov Andersen, MD, Lars Kjeldsen, MD, PhD, Lars Möllgård, MD, Eva Hellstrom-Lindberg, MD, PhD, Johan Jendholm, MSc, Bo T. Porse, PhD, Peter A. Jones, PhD, DSc, Gangning Liang, PhD, Kirsten Grønbæk, MD, DMSc

Blood (2011) 118 (21): 3450.

https://doi.org/10.1182/blood.V118.21.3450.3450

Published: 2011

Journal Articles

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

Kjeld Schmiegelow, Ibrahim Al-Modhwahi, Mette Klarskov Andersen, Mikael Behrendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, Richard Weinshilboum

Blood (2009) 113 (24): 6077–6084.

https://doi.org/10.1182/blood-2008-11-187880

Published: 2009

Journal Articles

Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

Kjeld Schmiegelow, Ibrahim Al-Modhawi, Mette Klarskov Andersen, Mikael Berendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, Richard Weinshilboum

Blood (2009) 113 (24): 6258–6259.

https://doi.org/10.1182/blood-2009-03-210195

Published: 2009

Journal Articles

Familial Myelodysplastic Syndromes with Centromere Instability of Chromosome 1 Origin.

Klas Raaschou-Jensen, MD, Mette Klarskov Andersen, MD,PhD, Bendt Nielsen, MD,PhD, Eigil Kjeldsen, MD,PhD, Lars Kjeldsen, MD,PhD

Blood (2006) 108 (11): 4855.

https://doi.org/10.1182/blood.V108.11.4855.4855

Published: 2006

Journal Articles

Therapy-related MDS and AML in acute promyelocytic leukemia

Mette Klarskov Andersen, Jens Pedersen-Bjergaard

Blood (2002) 100 (5): 1928–1930.

https://doi.org/10.1182/blood-2002-03-0962

Published: 2002

Journal Articles

Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation

Jens Pedersen-Bjergaard, Mette Klarskov Andersen, Debes H. Christiansen

Blood (2000) 95 (11): 3273–3279.

https://doi.org/10.1182/blood.V95.11.3273

Published: 2000

Journal Articles

Somatic Fas Mutations in Non-Hodgkin’s Lymphoma: Association With Extranodal Disease and Autoimmunity

Kirsten Grønbæk, Per thor Straten, Elisabeth Ralfkiaer, Vibeke Ahrenkiel, Mette Klarskov Andersen, Niels Ebbe Hansen, Jesper Zeuthen, Klaus Hou-Jensen, Per Guldberg

Blood (1998) 92 (9): 3018–3024.

https://doi.org/10.1182/blood.V92.9.3018

Published: 1998

NARROW

Risk of Cancer in Relatives of Patients with Myelodysplastic Neoplasia and Acute Leukemias

Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10 % Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL

Overall Survival in Patients with Ccus Depends on Presence of Anemia

Germline Variant in ZCCHC8 Is Associated with Pulmonary Fibrosis, Bone Marrow Failure, Liver Inflammation, Early Grey Hair and Short Telomer Length

Acquired Loss of a Sex Chromosome Is a Positive Prognostic Factor for Patients with Multiple Myeloma Undergoing ASCT

The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy

Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Intra-Tumoral Blast Heterogeneity and Implications for Minimal Residual Disease Detection in T-Cell Acute Lymphoblastic Leukemia

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML

MicroRNA-130a–mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors

Mir-130a-Mediated Downregulation of SMAD4 Contributes to Reduced Sensitivity to TGFβ Stimulation in Promyelocytic Cells,

Allelic Methylation Levels of the Non-Coding RNA Gene VTRNA2-1 Located on Chromosome 5q31.1 Predict Outcome in AML,

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

Familial Myelodysplastic Syndromes with Centromere Instability of Chromosome 1 Origin.

Therapy-related MDS and AML in acute promyelocytic leukemia

Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation

Somatic Fas Mutations in Non-Hodgkin’s Lymphoma: Association With Extranodal Disease and Autoimmunity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only